G Breuer, DR Weiss, J Ringwald - Current Opinion in …, 2014 - journals.lww.com
NOACs like dabigatran etexilate, rivaroxaban, apixaban and edoxaban are effective
alternatives to warfarin in primary and secondary prophylaxis of thromboembolic conditions …